Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Key Ratios

Price & Volume
Recent Price$0.30
52 Week High$1.89
52 Week Low$0.27
Average Volume (30 days)228.35K
Share Related Items
Market Cap$26.32M
Shares Outstanding88.51M
Dividend Information
Yield %--
Annual Dividend--
Payout Ratio-833.3%
Financial Strength
Quick Ratio (MRQ)19.8
Current Ratio (MRQ)20.3
LT Debt/Capital (MRQ)3%
Total Debt/Equity (MRQ)3%
Valuation Ratios
Price/Earnings (TTM)7.70
Price/Sales (TTM)52.65
Price/Book (MRQ)0.74
Price/Cash Flow (TTM)--
Per Share Data
Earnings (TTM)($0.14)
Sales (TTM)$0.01
Book Value (MRQ)$0.40
Cash Flow (TTM)($0.13)
Cash (MRQ)$0.37
Management Effectiveness
Return on Equity (TTM)-27.4%
Return on Assets (TTM)-24.7%
Return on Investment (TTM)11.0%
Gross Margin (TTM)-1,611.4%
EBIT Margin (TTM)25.0%
Profit Margin (TTM)19.0%